Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 01 04:00PM ET
10.34
Dollar change
+0.09
Percentage change
0.88
%
Index- P/E- EPS (ttm)-0.98 Insider Own- Shs Outstand9.30M Perf Week-1.43%
Market Cap95.33M Forward P/E- EPS next Y- Insider Trans- Shs Float4.30M Perf Month-1.99%
Income-8.30M PEG- EPS next Q- Inst Own- Short Float / Ratio0.00% / 0.00 Perf Quarter-
Sales6.19M P/S15.41 EPS this Y- Inst Trans- Short Interest0.00M Perf Half Y-
Book/sh4.20 P/B2.46 EPS next Y- ROA- Target Price- Perf Year-
Cash/sh2.65 P/C3.91 EPS next 5Y- ROE- 52W Range10.15 - 21.67 Perf YTD-17.28%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-52.28% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low1.87% ATR0.31
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)42.85 Volatility0.78% 1.75%
OptionableNo Debt/Eq0.00 EPS Q/Q- Profit Margin- Rel Volume0.12 Prev Close10.25
ShortableYes LT Debt/Eq0.00 EarningsNov 15 AMC Payout- Avg Volume24.79K Price10.34
Recom- SMA20-1.61% SMA50-4.34% SMA200-4.34% Volume3,095 Change0.88%
MDB Capital Holdings, LLC, through its subsidiaries, primarily operates as a broker-dealer. The company operates through two segments, Broker Dealer & Intellectual Property Service, and Technology Development. The Broker Dealer & Intellectual Property Service segment operates as a full-service broker dealer that focuses on conducting private and public securities offerings, as well as providing research services for investment banking due diligence. The Technology Development segment engages in the synthetic biology technology development business. The company was founded in 1997 and is based in Addison, Texas.